Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Charles River Laboratories International leads the 115 health care companies ranked by P/E ratio, at 362, ahead of Takeda Pharmaceutical (304) and Waters (195). Figures as of 19 Nov 2026, 10:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- First
- Charles River Laboratories International362
- Median
- 30.7
- Combined market value
- PLN 36.54T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Charles River Laboratories InternationalCRL · Health Care | 362 | PLN 64.2B | PLN 1,338.96 | 0.33% up | 105% up | ||
| 2 | Takeda PharmaceuticalTAK · Health Care | 304 | PLN 273B | PLN 85.46 | 1.71% down | 54% up | ||
| 3 | WatersWAT · Health Care | 195 | PLN 368.1B | PLN 1,872.73 | 3.63% up | 20% up | ||
| 4 | Merck & CoMRK · Health Care | 139 | PLN 1.36T | PLN 553.58 | 3.90% down | 51% up | ||
| 5 | Ligand PharmaceuticalsLGND · Health Care | 120 | PLN 24B | PLN 1,200.18 | 1.67% up | 43% up | ||
| 6 | BiogenBIIB · Health Care | 109 | PLN 149.3B | PLN 1,010.13 | 0.25% up | 49% up | ||
| 7 | BillionToOneBLLN · Health Care | 99.5 | PLN 17.6B | PLN 367.80 | 6.11% down | 0% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | 98.7 | PLN 40.2B | PLN 265.66 | 5.44% up | 107% up | ||
| 9 | Teva Pharmaceutical IndustriesTEVA · Health Care | 98.2 | PLN 198B | PLN 169.67 | 0.92% down | 74% up | ||
| 10 | SolventumSOLV · Health Care | 97.2 | PLN 59.1B | PLN 347.47 | 0.49% up | 11% up | ||
| 11 | MedlineMDLN · Health Care | 89.0 | PLN 207.1B | PLN 157.34 | 3.93% up | 8% down | ||
| 12 | TeleflexTFX · Health Care | 81.7 | PLN 26.4B | PLN 666.36 | 3.95% up | 51% up | ||
| 13 | PenumbraPEN · Health Care | 80.8 | PLN 50.8B | PLN 1,288.13 | 0.47% up | 13% up | ||
| 14 | ICONICLR · Health Care | 78.1 | PLN 58.7B | PLN 784.13 | 0.07% up | 23% up | ||
| 15 | LifeStance Health GroupLFST · Health Care | 76.5 | PLN 21B | PLN 55.33 | 2.82% down | 129% up | ||
| 16 | Jazz PharmaceuticalsJAZZ · Health Care | 73.3 | PLN 63.9B | PLN 995.51 | 2.93% up | 37% up | ||
| 17 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 72.0 | PLN 30B | PLN 381.90 | 0.06% down | 126% up | ||
| 18 | HeartflowHTFL · Health Care | 68.5 | PLN 16.2B | PLN 184.38 | 2.51% down | 73% up | ||
| 19 | RevvityRVTY · Health Care | 67.7 | PLN 68.4B | PLN 612.44 | 3.14% up | 60% up | ||
| 20 | Bio-TechneTECH · Health Care | 66.7 | PLN 45.9B | PLN 292.30 | 0.17% up | 26% up | ||
| 21 | Edwards LifesciencesEW · Health Care | 61.2 | PLN 243.1B | PLN 422.80 | 0.19% down | 23% up | ||
| 22 | IncyteINCY · Health Care | 60.1 | PLN 96.5B | PLN 473.31 | 1.08% down | 18% up | ||
| 23 | AlconALC · Health Care | 54.9 | PLN 145.3B | PLN 302.38 | 1.55% up | 2% down | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 54.7 | PLN 30.6B | PLN 87.91 | 3.60% up | 83% up | ||
| 25 | HaemoneticsHAE · Health Care | 54.4 | PLN 22.5B | PLN 493.64 | 1.60% up | 61% up | ||
| 26 | BeOne MedicinesONC · Health Care | 51.7 | PLN 185.2B | PLN 1,621.61 | 2.34% down | 17% up | ||
| 27 | Corcept TherapeuticsCORT · Health Care | 51.0 | PLN 29.8B | PLN 272.37 | 3.25% down | 8% down | ||
| 28 | Intuitive SurgicalISRG · Health Care | 50.9 | PLN 586.3B | PLN 1,691.32 | 2.23% down | 24% down | ||
| 29 | AbbVieABBV · Health Care | 49.1 | PLN 2.03T | PLN 1,149.15 | 2.33% down | 26% up | ||
| 30 | BrightSpring Health ServicesBTSG · Health Care | 48.5 | PLN 54.6B | PLN 274.58 | 2.13% down | 116% up | ||
| 31 | IDEXX LaboratoriesIDXX · Health Care | 47.1 | PLN 221.1B | PLN 2,806.36 | 1.19% up | 1% down | ||
| 32 | West Pharmaceutical ServicesWST · Health Care | 45.3 | PLN 113.1B | PLN 1,623.30 | 2.44% down | 61% up | ||
| 33 | Royalty PharmaRPRX · Health Care | 44.9 | PLN 158.6B | PLN 275.91 | 0.01% down | 78% up | ||
| 34 | Eli LillyLLY · Health Care | 44.9 | PLN 4.95T | PLN 5,555.71 | 2.32% down | 35% up | ||
| 35 | GenmabGMAB · Health Care | 43.6 | PLN 126.3B | PLN 204.79 | 1.91% down | 70% up | ||
| 36 | Krystal BiotechKRYS · Health Care | 42.8 | PLN 37.5B | PLN 1,267.00 | 5.62% up | 46% up | ||
| 37 | Becton, DickinsonBDX · Health Care | 42.7 | PLN 236.5B | PLN 868.18 | 0.31% up | 43% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.6 | PLN 50.2B | PLN 60.19 | 1.28% up | 5% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | 41.4 | PLN 2.64T | PLN 1,095.67 | 2.15% down | 38% up | ||
| 40 | PfizerPFE · Health Care | 40.1 | PLN 642.6B | PLN 112.74 | 1.44% down | 14% up | ||
| 41 | Abbott LaboratoriesABT · Health Care | 39.0 | PLN 727B | PLN 419.79 | 0.22% down | 17% down | ||
| 42 | DanaherDHR · Health Care | 37.8 | PLN 646.1B | PLN 918.40 | 1.24% up | 2% up | ||
| 43 | Mettler-Toledo InternationalMTD · Health Care | 37.7 | PLN 138.8B | PLN 6,980.08 | 1.42% up | 22% up | ||
| 44 | HumanaHUM · Health Care | 37.6 | PLN 186.2B | PLN 1,550.01 | 12.98% down | 94% up | ||
| 45 | Thermo Fisher ScientificTMO · Health Care | 36.5 | PLN 1.03T | PLN 2,783.34 | 0.87% up | 20% up | ||
| 46 | IlluminaILMN · Health Care | 36.1 | PLN 127.6B | PLN 843.79 | 3.65% up | 69% up | ||
| 47 | Cardinal HealthCAH · Health Care | 36.0 | PLN 258.5B | PLN 1,118.25 | 0.33% down | 35% up | ||
| 48 | Medpace HoldingsMEDP · Health Care | 35.9 | PLN 72.7B | PLN 2,599.04 | 0.95% down | 10% up | ||
| 49 | HealthEquityHQY · Health Care | 35.1 | PLN 32.3B | PLN 390.98 | 4.45% down | 2% down | ||
| 50 | Agilent TechnologiesA · Health Care | 35.0 | PLN 200.9B | PLN 712.49 | 2.97% up | 19% up | ||
| 51 | Vertex PharmaceuticalsVRTX · Health Care | 34.5 | PLN 546.5B | PLN 2,155.39 | 0.42% up | 27% up | ||
| 52 | StrykerSYK · Health Care | 33.9 | PLN 486.6B | PLN 1,278.29 | 0.19% up | 13% down | ||
| 53 | argenxARGX · Health Care | 32.6 | PLN 237.8B | PLN 3,781.82 | 0.66% down | 4% up | ||
| 54 | DexComDXCM · Health Care | 32.5 | PLN 123.7B | PLN 331.55 | 0.59% up | 37% up | ||
| 55 | Merit Medical SystemsMMSI · Health Care | 32.2 | PLN 20.7B | PLN 345.26 | 1.70% up | 1% up | ||
| 56 | IQVIA HoldingsIQV · Health Care | 31.4 | PLN 170.7B | PLN 1,035.97 | 0.09% up | 18% up | ||
| 57 | STERISSTE · Health Care | 30.8 | PLN 101.3B | PLN 1,042.92 | 0.84% up | 1% up | ||
| 58 | AvantorAVTR · Health Care | 30.7 | PLN 41.8B | PLN 61.75 | 1.25% up | 38% up | ||
| 59 | Labcorp HoldingsLH · Health Care | 30.4 | PLN 121B | PLN 1,489.75 | 0.69% up | 41% up | ||
| 60 | NovartisNVS · Health Care | 29.6 | PLN 1.18T | PLN 623.61 | 2.46% down | 25% up | ||
| 61 | McKessonMCK · Health Care | 28.0 | PLN 503.1B | PLN 4,357.10 | 0.66% down | 28% up | ||
| 62 | Ensign GroupENSG · Health Care | 27.2 | PLN 42.9B | PLN 735.19 | 1.63% down | 4% up | ||
| 63 | LivaNovaLIVN · Health Care | 27.1 | PLN 20.9B | PLN 379.85 | 2.85% up | 71% up | ||
| 64 | Protagonist TherapeuticsPTGX · Health Care | 26.9 | PLN 33.3B | PLN 510.91 | 2.00% up | 46% up | ||
| 65 | QiagenQGEN · Health Care | 26.8 | PLN 41.1B | PLN 199.13 | 0.38% down | 12% up | ||
| 66 | PACS GroupPACS · Health Care | 26.3 | PLN 29.5B | PLN 186.03 | 4.63% down | 188% up | ||
| 67 | ChemedCHE · Health Care | 26.2 | PLN 28.5B | PLN 2,196.65 | 0.01% down | 27% up | ||
| 68 | Zimmer Biomet HoldingsZBH · Health Care | 26.1 | PLN 78.6B | PLN 415.13 | 1.20% up | 14% up | ||
| 69 | Koninklijke PhilipsPHG · Health Care | 25.9 | PLN 117.1B | PLN 119.77 | 0.27% down | 10% up | ||
| 70 | Quest DiagnosticsDGX · Health Care | 25.9 | PLN 114.8B | PLN 1,043.40 | 1.30% up | 38% up | ||
| 71 | AmgenAMGN · Health Care | 25.7 | PLN 964.7B | PLN 1,783.49 | 3.07% down | 34% up | ||
| 72 | Lantheus HoldingsLNTH · Health Care | 25.4 | PLN 26.8B | PLN 409.82 | 0.20% up | 93% up | ||
| 73 | AstraZenecaAZN · Health Care | 25.3 | PLN 1.11T | PLN 718.23 | 1.93% down | 2% up | ||
| 74 | Concentra Group Holdings ParentCON · Health Care | 24.8 | PLN 21.2B | PLN 168.67 | 0.94% down | 120% up | ||
| 75 | MedtronicMDT · Health Care | 24.7 | PLN 517.6B | PLN 404.68 | 1.56% down | 2% up | ||
| 76 | Neurocrine BiosciencesNBIX · Health Care | 24.2 | PLN 66.2B | PLN 654.35 | 1.84% down | 20% up | ||
| 77 | Halozyme TherapeuticsHALO · Health Care | 23.9 | PLN 43.9B | PLN 384.91 | 0.18% down | 37% up | ||
| 78 | Align TechnologyALGN · Health Care | 23.9 | PLN 46.4B | PLN 658.77 | 0.31% up | 22% up | ||
| 79 | Henry ScheinHSIC · Health Care | 23.5 | PLN 38.1B | PLN 344.29 | 3.32% up | 17% up | ||
| 80 | SanofiSNY · Health Care | 23.4 | PLN 454.6B | PLN 189.32 | 0.86% down | 4% down | ||
| 81 | CenteneCNC · Health Care | 23.2 | PLN 134.2B | PLN 271.01 | 7.03% down | 102% up | ||
| 82 | Option Care HealthOPCH · Health Care | 23.0 | PLN 19.1B | PLN 127.41 | 0.25% up | 14% up | ||
| 83 | InsuletPODD · Health Care | 22.9 | PLN 39B | PLN 562.42 | 3.69% down | 58% down | ||
| 84 | MSA SafetyMSA · Health Care | 22.8 | PLN 27.5B | PLN 712.97 | 2.67% up | 11% up | ||
| 85 | ResMedRMD · Health Care | 22.1 | PLN 137.1B | PLN 974.78 | 2.00% up | 3% down | ||
| 86 | United TherapeuticsUTHR · Health Care | 21.8 | PLN 98.8B | PLN 2,319.68 | 1.16% down | 23% up | ||
| 87 | Encompass HealthEHC · Health Care | 21.6 | PLN 53.2B | PLN 542.13 | 2.14% down | 23% up | ||
| 88 | Regeneron PharmaceuticalsREGN · Health Care | 20.9 | PLN 393B | PLN 3,799.02 | 1.28% down | 36% up | ||
| 89 | Cooper CompaniesCOO · Health Care | 20.9 | PLN 46.4B | PLN 244.09 | 0.05% up | 16% down | ||
| 90 | Smith & NephewSNN · Health Care | 20.6 | PLN 50.9B | PLN 121.82 | 0.62% down | 5% down | ||
| 91 | ExelixisEXEL · Health Care | 20.4 | PLN 67B | PLN 274.38 | 0.31% down | 63% up | ||
| 92 | UnitedHealth GroupUNH · Health Care | 20.0 | PLN 1.26T | PLN 1,405.89 | 10.21% down | 26% up | ||
| 93 | CencoraCOR · Health Care | 19.4 | PLN 267.1B | PLN 1,399.46 | 0.64% down | 3% down | ||
| 94 | Boston ScientificBSX · Health Care | 18.4 | PLN 254.2B | PLN 175.34 | 1.42% up | 56% down | ||
| 95 | Ascendis PharmaASND · Health Care | 17.8 | PLN 71.2B | PLN 1,086.15 | 0.32% down | 28% up | ||
| 96 | GE HealthCare TechnologiesGEHC · Health Care | 17.7 | PLN 152B | PLN 336.14 | 2.22% up | 13% up | ||
| 97 | Globus MedicalGMED · Health Care | 17.4 | PLN 37.5B | PLN 283.38 | 0.77% up | 16% down | ||
| 98 | Elevance HealthELV · Health Care | 17.0 | PLN 348B | PLN 1,610.52 | 7.63% down | 37% up | ||
| 99 | GSKGSK · Health Care | 16.9 | PLN 391.2B | PLN 195.19 | 1.34% down | 6% up | ||
| 100 | HCA HealthcareHCA · Health Care | 15.8 | PLN 399.8B | PLN 1,913.91 | 4.96% down | 4% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0179 PLN). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/E ratio?
Charles River Laboratories International (362), Takeda Pharmaceutical (304) and Waters (195) are the top three of the 115 health care companies ranked by P/E ratio as of 19 Nov 2026, 10:06 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of PLN 36.54T as of 19 Nov 2026, 10:06 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.